Nabriva Therapeutics (NASDAQ:NBRV) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research report report published on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance The firm has a market cap of $45.46 million, a price-to-earnings ratio of -0.07 and a beta of 1.53. […]
More Stories
Royal Bank of Canada (NYSE:RY) Receives Consensus Rating of “Buy” from Analysts
Royal Bank of Canada (NYSE:RY – Get Free Report) (TSE:RY) has been assigned an average rating of “Buy” from the...
Sphere Entertainment Co. (NYSE:SPHR) Receives $45.83 Average PT from Brokerages
Sphere Entertainment Co. (NYSE:SPHR – Get Free Report) has earned a consensus recommendation of “Hold” from the eight brokerages that...
Trustmark Co. (NASDAQ:TRMK) Receives Consensus Recommendation of “Hold” from Brokerages
Shares of Trustmark Co. (NASDAQ:TRMK – Get Free Report) have earned an average rating of “Hold” from the four research...
Short Interest in Hong Kong Exchanges and Clearing Limited (OTCMKTS:HKXCY) Grows By 1,042.9%
Hong Kong Exchanges and Clearing Limited (OTCMKTS:HKXCY – Get Free Report) saw a significant growth in short interest in the...
Eguana Technologies Inc. (OTCMKTS:EGTYF) Short Interest Update
Eguana Technologies Inc. (OTCMKTS:EGTYF – Get Free Report) was the target of a significant increase in short interest during the...
Heidelberger Druckmaschinen Aktiengesellschaft (OTCMKTS:HBGRF) Short Interest Update
Heidelberger Druckmaschinen Aktiengesellschaft (OTCMKTS:HBGRF – Get Free Report) was the target of a large growth in short interest in the...